Vaccines, human use300220 (Harmonized System 1992 for 6-digit)
2020 World Trade: $32.6B, Rnk 69 / 4613
2020 Top Exporter | Top Importer: $11.4B | $7.58B, Belgium | Belgium
2020 Product Complexity: 0.75, Rnk 1174 / 4783
2019 - 2020 Export Growth (CAGR): 1.11%, Rnk 1069 / 4613
2018 Mean Tariff: 0.86%, Rnk 6418 / 6538
2020 Share of World Trade: 0.19%, Rnk 69 / 4613
Overview This page contains the latest trade data of Vaccines, human use. In 2020, Vaccines, human use were the world's 69th most traded product, with a total trade of $32.6B. Between 2019 and 2020 the exports of Vaccines, human use grew by 1.11%, from $32.3B to $32.6B. Trade in Vaccines, human use represent 0.19% of total world trade.
Vaccines, human use are a part of Vaccines, blood, antisera, toxins and cultures.
Exports In 2020 the top exporters of Vaccines, human use were Belgium ($11.4B), Ireland ($6.07B), France ($4.41B), United States ($2.03B), and Italy ($1.7B).
Imports In 2020 the top importers of Vaccines, human use were Belgium ($7.58B), United States ($7.46B), Germany ($1.69B), China ($1.41B), and United Kingdom ($1.22B).
Tariffs In 2018 the average tariff for Vaccines, human use was 0.86%, making it the 6418th lowest tariff using the HS6 product classification.
Ranking Vaccines, human use ranks 1174th in the Product Complexity Index (PCI).
Description A vaccine is a substance that creates immunity against a disease. It is typically administered by injection, but may be administered orally or by aerosol. Vaccines can protect against many infectious diseases including measles, mumps, tetanus, polio, rubella, and hepatitis A.
The following visualization shows the latest trends on Vaccines, human use. Countries are shown based on data availability.
For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.
* Using January 2020 exchange rates when trade data is reported in local currency.
Trade By Country
Vaccines, human use are the world's 69th most traded product.
In 2020, the top exporters of Vaccines, human use were Belgium ($11.4B), Ireland ($6.07B), France ($4.41B), United States ($2.03B), and Italy ($1.7B).
In 2020, the top importers of Vaccines, human use were Belgium ($7.58B), United States ($7.46B), Germany ($1.69B), China ($1.41B), and United Kingdom ($1.22B).
Trade by country
Top Origin Growth (2019 - 2020): Belgium, $2.53B
Top Destination Growth (2019 - 2020): Belgium, $1.11B
Between 2019 and 2020, the exports of Vaccines, human use grew the fastest in Belgium ($2.53B), Italy ($632M), Netherlands ($223M), China ($179M), and Poland ($92.4M).
Between 2019 and 2020, the fastest growing importers of Vaccines, human use were Belgium ($1.11B), China ($549M), Spain ($368M), Poland ($218M), and Vietnam ($134M).
Cumulative market share
This chart shows the evolution of the market concentration of exports of Vaccines, human use.
In 2020, market concentration measured using Shannon Entropy, was 3.18. This means that most of the exports of Vaccines, human use are explained by 9 countries.
TOP NET EXPORTER (2020): Ireland, $5.72B
TOP NET IMPORTER (2020): United States, $5.43B
This map shows which countries export or import more of Vaccines, human use. Each country is colored based on the difference in exports and imports of Vaccines, human use during 2020.
In 2020, the countries that had a largest trade value in exports than in imports of Vaccines, human use were Ireland ($5.72B), Belgium ($3.86B), France ($3.7B), Italy ($1.23B), and India ($410M).
In 2020, the countries that had a largest trade value in imports than in exports of Vaccines, human use were United States ($5.43B), China ($1.12B), Germany ($1.08B), Brazil ($695M), and Spain ($462M).
This visualization shows the countries that have an important ratio of their trade related to Vaccines, human use. It is possible to select the main countries that export or import Vaccines, human use in the world, or by continent, as well as select the measure of interest.
The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.
Have questions, comments, or concerns?
Send us an e-mail: [email protected]
v5.1.14 lamb